Dantrolene-Induced Inhibition of Skeletal L-Type Ca(2+) Current Requires RyR1 Expression.
Dantrolene-Induced Inhibition of Skeletal L-Type Ca(2+) Current Requires RyR1 Expression.
Biomed Res Int. 2013; 2013: 390493
Bannister RA
Malignant hyperthermia (MH) is a pharmacogenetic disorder most often linked to mutations in the type 1 ryanodine receptor (RyR1) or the… Continue reading
Depression Counseling
Depression Counseling – Depression is a real psychological illness and is treatable through a variety of therapies. If you are struggling with Depression, talk to a counselor today!
Medicaid Expansion Will Also Expand Access to Mental Health Services… Continue reading
Drug and Alcohol Rehabilitation: Paraoxonase 1 Gene Polymorphism Does Not Affect Clopidogrel Response Variability but Is Associated With Clinical Outcome After PCI.
Paraoxonase 1 Gene Polymorphism Does Not Affect Clopidogrel Response Variability but Is Associated with Clinical Outcome after PCI.
Filed under: Drug and Alcohol Rehabilitation
PLoS One. 2013; 8(2): e52779
Park KW, Park JJ, Kang J, Jeon KH, Kang SH,… Continue reading
Rehab Centers: [Diagnosis and Treatment of Tarsal Coalitions and Synostoses in Children and Adolescents.]
[Diagnosis and treatment of tarsal coalitions and synostoses in children and adolescents.]
Filed under: Rehab Centers
Orthopade. 2013 Feb 8;
Hamel J
The majority of tarsal coalitions are located in the calcaneonavicular and talocalcaneal regions and other locations are… Continue reading
Drug Rehab Centers in Illinois | Alcohol Rehab Illinois | Drug Rehab Centers in Illinois
Drug Rehab Centers in Illinois | Alcohol Rehab Illinois | Drug Rehab Centers in Illinois – www.rehabil.net Drug Rehab Centers in Illinois help you get you life back. Alcohol Rehab Illinois help people in getting detox in IL, recovery… Continue reading
Individualization Through Standardization: Electronic Orders for Subcutaneous Insulin in the Hospital.
Individualization through standardization: electronic orders for subcutaneous insulin in the hospital.
Filed under: Eating Disorders
Endocr Pract. 2012 Nov 1; 18(6): 976-87
Kennihan M, Zohra T, Devi R, Srinivasan C, Diaz J, Howard BS, Braithwaite SS
Objective: The objective… Continue reading